I think this will be a big drug. Trial had a SPA and FDA agreed this trial in enough for approval.
Peter,
I agree with you. In light of that, doesn't it seem to you that today's price action was extremely muted? There are some cash issues going forward, but a small raise should be able to take care of that. And that's assuming no partnerships are made in the meantime. Do you see PRTK as a buy here?